Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
McKinsey
Colorcon
Medtronic
Harvard Business School

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC. (D.N.J. 2015)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC. (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-07-22
Court District Court, D. New Jersey Date Terminated 2018-09-18
Cause 35:271 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Lois H. Goodman
Parties UNITED THERAPEUTICS CORPORATION; WATSON LABORATORIES, INC.
Patents 6,521,212; 6,756,033; 8,497,393; 9,339,507; 9,358,240
Attorneys JOSEPH L. LINARES; LIZA M. WALSH; RAVIN R. PATEL; TRICIA B. O'REILLY; WILLIAM J. O'SHAUGHNESSY
Firms McCarter & English, LLP; McCarter and English, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for UNITED THERAPEUTICS CORPORATION v. WATSON LABORATORIES, INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2017-07-27 130 Hatch-Waxman patent case involving five patents: U.S. Patent Nos. 6,521,212 (“the ’212 patent”), 6,756,033…,033 (“the ’033 patent”), 8,497,393 (“the ’393 patent”), 9,339,507 (“the ’507 patent”), and 9,358,240… the patents-in-suit, the ‘393 patent, was determined to be invalid by the United States Patent and Trial…2017. Two additional patents-in-suit, the ‘507 and ‘240 patents, are currently the subject of…resolution of two recently-filed IPRs on two of the patents-in-suit. If the stipulation and proposed order External link to document
2018-01-16 137 Hatch-Waxman patent case involving five patents: U.S. Patent Nos. 6,521,212 (“the ’212 patent”), 6,756,033…,033 (“the ’033 patent”), 8,497,393 (“the ’393 patent”), 9,339,507 (“the ’507 patent”), and 9,358,240… the patents-in-suit, the ‘393 patent, was determined to be invalid by the United States Patent and Trial…certiorari. Two additional patents-in-suit, the ‘507 and ‘240 patents, are currently the subject of… 2019. The final two patents-in-suit, the ‘212 and ‘033 patents, are set to expire on November External link to document
2016-06-21 49 seq., involving United States Patent Nos. 6,521,212 (“the ’212 patent”) (attached as Exhibit A hereto…of the ’212 patent, the ’033 patent, the ’393 patent, the ’507 patent, and the ’240 patent, inclusive…the ’212 patent, the ’033 patent, the ’393 patent, the ’507 patent, and/or the ’240 patent, including…of the ’212 patent, the ’033 patent, the ’393 patent, the ’507 patent, and the ’240 patent, inclusive…the ’212 patent, the ’033 patent, the ’393 patent, the ’507 patent, and/or the ’240 patent prior to External link to document
2016-08-05 54 Correct INFRINGEMENT CONTENTIONS FOR U.S. PATENT NO. 8,497,393 by UNITED THERAPEUTICS CORPORATION. (Attachments… 18 September 2018 3:15-cv-05723 830 Patent None District Court, D. New Jersey External link to document
2016-08-05 55 Correct INFRINGEMENT CONTENTIONS FOR U.S. PATENT NO. 8,497,393 (Attachments: # 1 Declaration of ROBERT … 18 September 2018 3:15-cv-05723 830 Patent None District Court, D. New Jersey External link to document
2016-08-12 56 supplement infringement contentions for U.S. Patent No. 8,497,393)(O'SHAUGHNESSY, WILLIAM) (Entered: 08/12… 18 September 2018 3:15-cv-05723 830 Patent None District Court, D. New Jersey External link to document
2016-08-25 57 Correct INFRINGEMENT CONTENTIONS FOR U.S. PATENT NO. 8,497,393 (CONFIDENTIAL - FILED UNDER SEAL) (WALSH… 18 September 2018 3:15-cv-05723 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Johnson and Johnson
Merck
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.